Literature DB >> 8733366

Soluble intercellular adhesion molecule-1 and soluble E-selectin levels in patients with atopic dermatitis.

S Hirai1, T Kageshita, T Kimura, M Tsujisaki, K Okajima, K Imai, T Ono.   

Abstract

The serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble E-selectin (sE-selectin) were determined by double determinant immunoassay (DDIA), in 37 patients with atopic dermatitis (AD) and 31 age- and sex-matched healthy control subjects. Both sICAM-1 and sE-selectin levels were significantly higher in patients with AD than in healthy controls (P < 0.01), and were correlated with disease severity. A longitudinal study of patients with AD revealed that the levels of sICAM-1 decreased in those in whom symptoms improved. The sICAM-1 levels were significantly correlated with those of sE-selectin. Our studies suggest that such high levels of serum sICAM-1 and sE-selectin may affect the immune response in patients with AD. The levels of sICAM-1 and sE-selectin may be a useful immunological parameter for monitoring disease activity in AD.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8733366     DOI: 10.1111/j.1365-2133.1996.tb06965.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  5 in total

1.  Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis.

Authors:  T Kakinuma; K Nakamura; M Wakugawa; H Mitsui; Y Tada; H Saeki; H Torii; M Komine; A Asahina; K Tamaki
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

Review 2.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2013-11-27       Impact factor: 11.527

Review 3.  Specific immunotherapy in atopic dermatitis.

Authors:  Jungsoo Lee; Chang Ook Park; Kwang Hoon Lee
Journal:  Allergy Asthma Immunol Res       Date:  2014-11-25       Impact factor: 5.764

Review 4.  E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy.

Authors:  Mariana Silva; Paula A Videira; Robert Sackstein
Journal:  Front Immunol       Date:  2018-01-19       Impact factor: 7.561

5.  VCAM-1 blockade delays disease onset, reduces disease severity and inflammatory cells in an atopic dermatitis model.

Authors:  Lin Chen; Shao-xia Lin; Sanober Amin; Lut Overbergh; Giacomo Maggiolino; Lawrence S Chan
Journal:  Immunol Cell Biol       Date:  2010-01-12       Impact factor: 5.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.